Similar pregnancy outcomes from fresh and frozen donor oocytes transferred to gestational carriers: a SART database analysis isolating the effects of oocyte vitrification.

Fertility Gestational carrier Gestational surrogate Oocyte Oocyte freezing Vitrification

Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 28 07 2023
accepted: 21 12 2023
pubmed: 11 1 2024
medline: 11 1 2024
entrez: 10 1 2024
Statut: ppublish

Résumé

This work aimed to study clinical and neonatal outcomes of embryos derived from frozen compared to fresh donor oocytes in gestational carrier cycles. This is a retrospective cohort study using the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database between 2014 and 2015, comprising of 1284 fresh transfer cycles to gestational carrier recipients of embryos resulting from fresh (n = 1119) and vitrified/thawed (n = 165) donor oocytes. Models were adjusted for gestational carrier age, preimplantation genetic testing (PGT-A), number of embryos transferred, multiple gestation, and fetal heart reduction. As our models were part of a larger analysis, intended parent BMI, smoking status, and parity were also adjusted for, but did not influence outcomes in this analysis. There was no significant difference in probability of live birth rates when comparing embryos derived from fresh and frozen donor oocytes in gestational carrier cycles. There were also no significant differences in biochemical pregnancy losses or clinical miscarriage. There were no significant differences noted in low birthweight or high birthweight infants derived from fresh versus frozen donor oocyte after transfer into a gestational carrier. The analysis of fresh and frozen donor oocytes in gestational carrier cycles provides the opportunity to assess for a possible effect of vitrification on the oocyte by controlling for differences in the uterine environment. We observed no significant differences in live birth, pregnancy loss, low birthweight or high birthweight infants when comparing fresh and frozen donor oocytes in gestational carrier cycles.

Identifiants

pubmed: 38200285
doi: 10.1007/s10815-023-03016-2
pii: 10.1007/s10815-023-03016-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

643-648

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Centers for Disease Control and Prevention. Key statistics from the National Survey of Family Growth – I Listing National Center for Health Statistics [Available from: https://www.cdc.gov/nchs/nsfg/key_statistics/i-keystat.htm#infertility .
Barnhart KT. Assisted reproductive technologies and perinatal morbidity: interrogating the association. Fertil Steril. 2013;99(2):299–302.
doi: 10.1016/j.fertnstert.2012.12.032 pubmed: 23375143 pmcid: 3564059
Simopoulou M, Sfakianoudis K, Tsioulou P, Rapani A, Anifandis G, Pantou A, et al. Risks in surrogacy considering the embryo: from the preimplantation to the gestational and neonatal period. Biomed Res Int. 2018;2018:6287507.
doi: 10.1155/2018/6287507 pubmed: 30112409 pmcid: 6077588
Center for Disease Control and Prevention. 2020 Assisted reproductive technology fertility clinic and national summary report. US dept of health and human services. 2022.
Chang HY, Hwu WL, Chen CH, Hou CY, Cheng W. Children conceived by assisted reproductive technology prone to low birth weight, preterm birth, and birth defects: a cohort review of more than 50,000 live births during 2011–2017 in Taiwan. Front Pediatr. 2020;8:87.
doi: 10.3389/fped.2020.00087 pubmed: 32232018 pmcid: 7082315
Homer HA. The role of oocyte quality in explaining “unexplained” unfertility. Semin Reprod Med. 2020;38(1):21–8.
doi: 10.1055/s-0040-1721377 pubmed: 33232987
Setti AS, Figueira RC, Braga DP, Colturato SS, Iaconelli A Jr, Borges E Jr. Relationship between oocyte abnormal morphology and intracytoplasmic sperm injection outcomes: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2011;159(2):364–70.
doi: 10.1016/j.ejogrb.2011.07.031 pubmed: 21824710
Catala MG, Izquierdo D, Rodriguez-Prado M, Hammami S, Paramio MT. Effect of oocyte quality on blastocyst development after in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in a sheep model. Fertil Steril. 2012;97(4):1004–8.
doi: 10.1016/j.fertnstert.2011.12.043 pubmed: 22265000
Kaser DJ, Reichman DE, Ginsburg ES, Politch JA, Racowsky C. Developmental potential of embryos from intracytoplasmic sperm injection cycles containing fragmented oocytes. Fertil Steril. 2012;97(2):338–43.
doi: 10.1016/j.fertnstert.2011.11.013 pubmed: 22153788
Segal TR, Kim K, Mumford SL, Goldfarb JM, Weinerman RS. How much does the uterus matter? Perinatal outcomes are improved when donor oocyte embryos are transferred to gestational carriers compared to intended parent recipients. Fertil Steril. 2018;110(5):888–95.
doi: 10.1016/j.fertnstert.2018.06.015 pubmed: 30316434 pmcid: 7994022
Practice Committees of the American Society for Reproductive M, Society of Reproductive B, Technologists. Electronic address jao. A review of best practices of rapid-cooling vitrification for oocytes and embryos: a committee opinion. Fertil Steril. 2021;115(2):305–10.
Rudick B, Opper N, Paulson R, Bendikson K, Chung K. The status of oocyte cryopreservation in the United States. Fertil Steril. 2010;94(7):2642–6.
doi: 10.1016/j.fertnstert.2010.04.079 pubmed: 20723535
Cobo A, Serra V, Garrido N, Olmo I, Pellicer A, Remohi J. Obstetric and perinatal outcome of babies born from vitrified oocytes. Fertil Steril. 2014;102(4):1006-15 e4.
doi: 10.1016/j.fertnstert.2014.06.019 pubmed: 25064408
Shih W, Rushford DD, Bourne H, Garrett C, McBain JC, Healy DL, et al. Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection. Hum Reprod. 2008;23(7):1644–53.
doi: 10.1093/humrep/den150 pubmed: 18442997
Wei D, Liu JY, Sun Y, Shi Y, Zhang B, Liu JQ, et al. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. Lancet. 2019;393(10178):1310–8.
doi: 10.1016/S0140-6736(18)32843-5 pubmed: 30827784
Roque M, Haahr T, Geber S, Esteves SC, Humaidan P. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Hum Reprod Update. 2019;25(1):2–14.
doi: 10.1093/humupd/dmy033 pubmed: 30388233
Centers for Disease Control and Prevention. 2015 Assisted reproductive technology fertility clinic and national summary report. US dept of health and human services. 2017.
Da Luz CM, Caetano MA, Berteli TS, Vireque AA, Navarro PA. The impact of oocyte vitrification on offspring: a systematic review. Reprod Sci. 2022;29(11):3222–34.
doi: 10.1007/s43032-022-00868-4 pubmed: 35099778
Centers for Disease Control and Prevention. 2019 Assisted reproductive technology fertility clinic and national summary report. US dept of health and human services. 2021.
Practice Committee of the American Society for Reproductive Medicine. Electronic address Aao, Practice Committee of the Society for Assisted Reproductive T. Guidance on the limits to the number of embryos to transfer: a committee opinion. Fertil Steril. 2017;107(4):901–3.

Auteurs

Jacqueline Kloos (J)

Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Channing Burks (C)

Fertility Centers of Illinois, Chicago, IL, USA.

Alexandra Purdue-Smithe (A)

Division of Women's Health, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Elizabeth DeVilbiss (E)

Division of Population Health Research, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.

Sunni L Mumford (SL)

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Rachel Weinerman (R)

Division of Reproductive Endocrinology and Infertility, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. Rachel.Weinerman@UHhospitals.org.

Classifications MeSH